{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T04:56:08Z","timestamp":1790916968128,"version":"4.1.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2026,10]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The impact of sentinel lymph node dissection (SLND) or targeted axillary dissection (TAD) prior to axillary lymph node dissection (ALND) on the technical success of immediate lymphatic reconstruction (ILR) is not well described. We aimed to determine if the technical success of ILR varies by timing of surgical axillary staging prior to ALND.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Our departmental database was queried to identify patients undergoing ALND from 2020 to 2024. Type and timing of axillary surgical staging and ILR technical details were collected by retrospective chart review.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Among 866 patients undergoing ALND with a plan for ILR, 655 (75.6%) underwent single-stage ALND, 120 (13.9%) underwent SLND\/TAD followed by ALND under the same anesthetic, and 91 (10.5%) underwent SLND\/TAD followed by ALND at a separate surgery. The overall ILR technical success rate was 93.4% (612\/655). Immediate lymphatic reconstruction technical success did not vary significantly between groups (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.415). Groups were similar in number of reconstructed lymphatic channels (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.173), with a median of 2 (IQR 1\u20133) channels. The most common reasons for ILR not being performed (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200952) included failure to identify blue lymphatic channels by axillary reverse mapping (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200921) and no suitable veins for the reconstruction (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200911). On multivariable analysis, White race and lower body mass index were significant predictors of ILR technical success.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>In patients undergoing ALND, ILR was successfully performed in &gt;\u200990% of cases, irrespective of concurrent or staged SLND\/TAD procedures. Most patients (62.9%) had at least 2 lymphatic channels reconstructed. Deferring decision-making about completion ALND for final pathology from SLND\/TAD does not appear to negatively impact technical success of ILR.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1245\/s10434-026-20142-0","type":"journal-article","created":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T05:55:03Z","timestamp":1782971703000},"page":"9731-9738","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Timing of Surgical Axillary Staging and Impact on Technical Success of Immediate Lymphatic Reconstruction Following Axillary Lymph Node Dissection"],"prefix":"10.1245","volume":"33","author":[{"given":"Helen M.","family":"Johnson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susie X.","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David M.","family":"Adelman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward I.","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Solange","family":"Cox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shannon","family":"Foreman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maggie","family":"Keener","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren","family":"Patterson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona F.","family":"Shaitelman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly K.","family":"Hunt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah M.","family":"DeSnyder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,1]]},"reference":[{"issue":"9","key":"20142_CR1","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1093\/jnci\/djj158","volume":"98","author":"RE Mansel","year":"2006","unstructured":"Mansel RE, Fallowfield L, Kissin M, et al. Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: the ALMANAC trial. J Natl Cancer Inst. 2006;98(9):599\u2013609.","journal-title":"J Natl Cancer Inst"},{"issue":"24","key":"20142_CR2","doi-asserted-by":"publisher","first-page":"3657","DOI":"10.1200\/JCO.2006.07.4062","volume":"25","author":"A Lucci","year":"2007","unstructured":"Lucci A, McCall LM, Beitsch PD, et al. Surgical complications associated with sentinel lymph node dissection (SLND) plus axillary lymph node dissection compared with SLND alone in the American College of Surgeons Oncology Group Trial Z0011. J Clin Oncol. 2007;25(24):3657\u201363.","journal-title":"J Clin Oncol"},{"issue":"2","key":"20142_CR3","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1002\/jso.21535","volume":"102","author":"T Ashikaga","year":"2010","unstructured":"Ashikaga T, Krag DN, Land SR, et al. Morbidity results from the NSABP B-32 trial comparing sentinel lymph node dissection versus axillary dissection. J Surg Oncol. 2010;102(2):111\u20138.","journal-title":"J Surg Oncol"},{"issue":"7","key":"20142_CR4","doi-asserted-by":"publisher","first-page":"1959","DOI":"10.1245\/s10434-009-0452-2","volume":"16","author":"RJ Tsai","year":"2009","unstructured":"Tsai RJ, Dennis LK, Lynch CF, Snetselaar LG, Zamba GK, Scott-Conner C. The risk of developing arm lymphedema among breast cancer survivors: a meta-analysis of treatment factors. Ann Surg Oncol. 2009;16(7):1959\u201372.","journal-title":"Ann Surg Oncol"},{"issue":"4","key":"20142_CR5","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1016\/j.ijrobp.2011.09.058","volume":"83","author":"C Shah","year":"2012","unstructured":"Shah C, Wilkinson JB, Baschnagel A, et al. Factors associated with the development of breast cancer-related lymphedema after whole-breast irradiation. Int J Radiat Oncol Biol Phys. 2012;83(4):1095\u2013100.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"7","key":"20142_CR6","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1200\/JCO.2015.61.5948","volume":"34","author":"CM Ferguson","year":"2016","unstructured":"Ferguson CM, Swaroop MN, Horick N, et al. Impact of ipsilateral blood draws, injections, blood pressure measurements, and air travel on the risk of lymphedema for patients treated for breast cancer. J Clin Oncol. 2016;34(7):691\u20138.","journal-title":"J Clin Oncol"},{"issue":"32","key":"20142_CR7","doi-asserted-by":"publisher","first-page":"5213","DOI":"10.1200\/JCO.2008.16.3725","volume":"26","author":"SA McLaughlin","year":"2008","unstructured":"McLaughlin SA, Wright MJ, Morris KT, et al. Prevalence of lymphedema in women with breast cancer 5 years after sentinel lymph node biopsy or axillary dissection: objective measurements. J Clin Oncol. 2008;26(32):5213\u20139.","journal-title":"J Clin Oncol"},{"issue":"3","key":"20142_CR8","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/j.ijrobp.2013.11.232","volume":"88","author":"LE Warren","year":"2014","unstructured":"Warren LE, Miller CL, Horick N, et al. The impact of radiation therapy on the risk of lymphedema after treatment for breast cancer: a prospective cohort study. Int J Radiat Oncol Biol Phys. 2014;88(3):565\u201371.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"29","key":"20142_CR9","doi-asserted-by":"publisher","first-page":"3430","DOI":"10.1200\/JCO.20.00459","volume":"38","author":"GE Naoum","year":"2020","unstructured":"Naoum GE, Roberts S, Brunelle CL, et al. Quantifying the impact of axillary surgery and nodal irradiation on breast cancer-related lymphedema and local tumor control: long-term results from a prospective screening trial. J Clin Oncol. 2020;38(29):3430\u20138.","journal-title":"J Clin Oncol"},{"key":"20142_CR10","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.breast.2016.04.011","volume":"28","author":"SL Kilbreath","year":"2016","unstructured":"Kilbreath SL, Refshauge KM, Beith JM, et al. Risk factors for lymphoedema in women with breast cancer: a large prospective cohort. Breast. 2016;28:29\u201336.","journal-title":"Breast"},{"issue":"8","key":"20142_CR11","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1001\/jamaoncol.2022.1628","volume":"8","author":"G Montagna","year":"2022","unstructured":"Montagna G, Zhang J, Sevilimedu V, et al. Risk factors and racial and ethnic disparities in patients with breast cancer-related lymphedema. JAMA Oncol. 2022;8(8):1195\u2013200.","journal-title":"JAMA Oncol"},{"issue":"9","key":"20142_CR12","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1001\/jamasurg.2023.2414","volume":"158","author":"DH Rochlin","year":"2023","unstructured":"Rochlin DH, Barrio AV, McLaughlin S, et al. Feasibility and clinical utility of prediction models for breast cancer-related lymphedema incorporating racial differences in disease incidence. JAMA Surg. 2023;158(9):954\u201364.","journal-title":"JAMA Surg"},{"issue":"3","key":"20142_CR13","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1245\/s10434-008-0270-y","volume":"16","author":"F Boccardo","year":"2009","unstructured":"Boccardo F, Casabona F, De Cian F, et al. Lymphedema microsurgical preventive healing approach: a new technique for primary prevention of arm lymphedema after mastectomy. Ann Surg Oncol. 2009;16(3):703\u20138.","journal-title":"Ann Surg Oncol"},{"issue":"6","key":"20142_CR14","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1002\/micr.22254","volume":"34","author":"F Boccardo","year":"2014","unstructured":"Boccardo F, Casabona F, De Cian F, et al. Lymphatic microsurgical preventing healing approach (LYMPHA) for primary surgical prevention of breast cancer-related lymphedema: over 4 years follow-up. Microsurgery. 2014;34(6):421\u20134.","journal-title":"Microsurgery"},{"issue":"10","key":"20142_CR15","doi-asserted-by":"publisher","first-page":"3296","DOI":"10.1245\/s10434-015-4721-y","volume":"22","author":"S Feldman","year":"2015","unstructured":"Feldman S, Bansil H, Ascherman J, et al. Single institution experience with lymphatic microsurgical preventive healing approach (LYMPHA) for the primary prevention of lymphedema. Ann Surg Oncol. 2015;22(10):3296\u2013301.","journal-title":"Ann Surg Oncol"},{"issue":"5","key":"20142_CR16","doi-asserted-by":"publisher","first-page":"773e","DOI":"10.1097\/PRS.0000000000010381","volume":"152","author":"MD Granoff","year":"2023","unstructured":"Granoff MD, Fleishman A, Shillue K, et al. A 4-year institutional experience of immediate lymphatic reconstruction. Plast Reconstr Surg. 2023;152(5):773e-e778.","journal-title":"Plast Reconstr Surg"},{"issue":"4","key":"20142_CR17","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1097\/SLA.0000000000005952","volume":"278","author":"M Coriddi","year":"2023","unstructured":"Coriddi M, Dayan J, Bloomfield E, et al. Efficacy of immediate lymphatic reconstruction to decrease incidence of breast cancer-related lymphedema: preliminary results of randomized controlled trial. Ann Surg. 2023;278(4):630\u20137.","journal-title":"Ann Surg"},{"issue":"4","key":"20142_CR18","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1055\/a-2153-2203","volume":"40","author":"NK Le","year":"2024","unstructured":"Le NK, Weinstein B, Parikh J, et al. Immediate lymphatic reconstruction in 77 consecutive breast cancer patients: 2-year follow-up. J Reconstr Microsurg. 2024;40(4):262\u20137.","journal-title":"J Reconstr Microsurg"},{"issue":"6","key":"20142_CR19","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1097\/SLA.0000000000002827","volume":"270","author":"T Ozmen","year":"2019","unstructured":"Ozmen T, Lazaro M, Zhou Y, Vinyard A, Avisar E. Evaluation of simplified lymphatic microsurgical preventing healing approach (S-LYMPHA) for the prevention of breast cancer-related clinical lymphedema after axillary lymph node dissection. Ann Surg. 2019;270(6):1156\u201360.","journal-title":"Ann Surg"},{"issue":"5","key":"20142_CR20","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1016\/j.jamcollsurg.2007.12.022","volume":"206","author":"C Boneti","year":"2008","unstructured":"Boneti C, Korourian S, Bland K, et al. Axillary reverse mapping: mapping and preserving arm lymphatics may be important in preventing lymphedema during sentinel lymph node biopsy. J Am Coll Surg. 2008;206(5):1038\u201342 (discussion 1042\u20134).","journal-title":"J Am Coll Surg"},{"issue":"5","key":"20142_CR21","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1016\/j.surg.2014.05.011","volume":"156","author":"D Ochoa","year":"2014","unstructured":"Ochoa D, Korourian S, Boneti C, Adkins L, Badgwell B, Klimberg VS. Axillary reverse mapping: five-year experience. Surgery. 2014;156(5):1261\u20138.","journal-title":"Surgery"},{"issue":"5","key":"20142_CR22","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1097\/SAP.0000000000004681","volume":"96","author":"JK Shah","year":"2026","unstructured":"Shah JK, Silverstein M, Nazerali R. Immediate lymphatic reconstruction to prevent postmastectomy lymphedema: a national analysis of outcomes and regional trends. Ann Plast Surg. 2026;96(5):413\u20139.","journal-title":"Ann Plast Surg"},{"issue":"20","key":"20142_CR23","doi-asserted-by":"publisher","first-page":"1937","DOI":"10.1056\/NEJMcp1803290","volume":"379","author":"SG Rockson","year":"2018","unstructured":"Rockson SG. Lymphedema after breast cancer treatment. N Engl J Med. 2018;379(20):1937\u201344.","journal-title":"N Engl J Med"},{"issue":"1","key":"20142_CR24","first-page":"43","volume":"66","author":"CD Runowicz","year":"2016","unstructured":"Runowicz CD, Leach CR, Henry NL, et al. American Cancer Society\/American Society of clinical oncology breast cancer survivorship care guideline. CA Cancer J Clin. 2016;66(1):43\u201373.","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"20142_CR25","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1245\/s10434-025-18333-2","volume":"33","author":"S Brown","year":"2026","unstructured":"Brown S, Shen Y, Klimitz FJ, et al. Immediate lymphatic reconstruction (ILR) for the prevention of lymphedema: a meta-analysis of prospective clinical trials. Ann Surg Oncol. 2026;33(1):60\u201376.","journal-title":"Ann Surg Oncol"},{"issue":"4","key":"20142_CR26","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1097\/SLA.0000000000001375","volume":"263","author":"JC Boughey","year":"2016","unstructured":"Boughey JC, Ballman KV, Le-Petross HT, et al. Identification and resection of clipped node decreases the false-negative rate of sentinel lymph node surgery in patients presenting with node-positive breast cancer (T0\u2013T4, N1\u2013N2) who receive neoadjuvant chemotherapy: results from ACOSOG Z1071 (Alliance). Ann Surg. 2016;263(4):802\u20137.","journal-title":"Ann Surg"},{"issue":"3","key":"20142_CR27","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1200\/JCO.2014.55.7827","volume":"33","author":"JF Boileau","year":"2015","unstructured":"Boileau JF, Poirier B, Basik M, et al. Sentinel node biopsy after neoadjuvant chemotherapy in biopsy-proven node-positive breast cancer: the SN FNAC study. J Clin Oncol. 2015;33(3):258\u201364.","journal-title":"J Clin Oncol"},{"issue":"7","key":"20142_CR28","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1016\/S1470-2045(13)70166-9","volume":"14","author":"T Kuehn","year":"2013","unstructured":"Kuehn T, Bauerfeind I, Fehm T, et al. Sentinel-lymph-node biopsy in patients with breast cancer before and after neoadjuvant chemotherapy (SENTINA): a prospective, multicentre cohort study. Lancet Oncol. 2013;14(7):609\u201318.","journal-title":"Lancet Oncol"},{"issue":"10","key":"20142_CR29","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1200\/JCO.2015.64.0094","volume":"34","author":"AS Caudle","year":"2016","unstructured":"Caudle AS, Yang WT, Krishnamurthy S, et al. Improved axillary evaluation following neoadjuvant therapy for patients with node-positive breast cancer using selective evaluation of clipped nodes: implementation of targeted axillary dissection. J Clin Oncol. 2016;34(10):1072\u20138.","journal-title":"J Clin Oncol"},{"issue":"4","key":"20142_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejso.2024.108245","volume":"50","author":"C Loveland-Jones","year":"2024","unstructured":"Loveland-Jones C, Gaughan J, Caudle A, et al. Evaluation of traditional targeted axillary dissection eligibility criteria for node-positive breast cancer after neoadjuvant chemotherapy in a prospective multicenter registry. Eur J Surg Oncol. 2024;50(4):108245.","journal-title":"Eur J Surg Oncol"},{"issue":"1","key":"20142_CR31","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1245\/s10434-023-14521-0","volume":"31","author":"PN Haravu","year":"2024","unstructured":"Haravu PN, Shakir A, Jackson K, et al. Establishment and feasibility of an immediate lymphatic reconstruction program in a community health system. Ann Surg Oncol. 2024;31(1):672\u201380.","journal-title":"Ann Surg Oncol"},{"issue":"3","key":"20142_CR32","doi-asserted-by":"publisher","first-page":"373e","DOI":"10.1097\/PRS.0000000000007636","volume":"147","author":"AR Johnson","year":"2021","unstructured":"Johnson AR, Fleishman A, Granoff MD, et al. Evaluating the impact of immediate lymphatic reconstruction for the surgical prevention of lymphedema. Plast Reconstr Surg. 2021;147(3):373e-e381.","journal-title":"Plast Reconstr Surg"},{"issue":"11","key":"20142_CR33","doi-asserted-by":"publisher","first-page":"7349","DOI":"10.1245\/s10434-024-15715-w","volume":"31","author":"JW Jakub","year":"2024","unstructured":"Jakub JW, Boughey JC, Hieken TJ, et al. Lymphedema rates following axillary lymph node dissection with and without immediate lymphatic reconstruction: a prospective trial. Ann Surg Oncol. 2024;31(11):7349\u201359.","journal-title":"Ann Surg Oncol"},{"issue":"6","key":"20142_CR34","doi-asserted-by":"publisher","first-page":"e1197","DOI":"10.1097\/SLA.0000000000005814","volume":"277","author":"DH Rochlin","year":"2023","unstructured":"Rochlin DH, Coriddi MR, Nelson JA, Dayan JH, Mehrara BJ. Immediate lymphatic reconstruction and the current value problem. Ann Surg. 2023;277(6):e1197\u20139.","journal-title":"Ann Surg"}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-026-20142-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-026-20142-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-026-20142-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T04:50:41Z","timestamp":1790916641000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-026-20142-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,1]]},"references-count":34,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["20142"],"URL":"https:\/\/doi.org\/10.1245\/s10434-026-20142-0","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,1]]},"assertion":[{"value":"23 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Simona Shaitelman\u2014Contracted research support from: Artidis, Radionetics, ExactSciences, and Lumicell. Grant from NCI\/NIH. Kelly Hunt\u2014Medical Advisory Board: ArmadaHealth, AstraZeneca, Daiichi Sankyo; Honorarium from Springer Nature; Editor-in-Chief\u2014Current Breast Cancer Reports; Research funding to MD Anderson Cancer Center: Cairn Surgical, Eli Lilly & Co., Lumicell. David Adelman\u2014Consultant for Integra Life Sciences (not related to this work).","order":1,"name":"Ethics","label":"Disclosure","group":{"name":"EthicsHeading","label":"Ethics"}}]}}